3 analysts have expressed a variety of opinions on MaxLinear (NASDAQ:MXL) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $20.67, a high estimate of $25.00, and a low estimate of $15.00. This current average represents a 18.4% decrease from the previous average price target of $25.33.

Breaking Down Analyst Ratings: A Detailed Examination

The analysis of recent analyst actions sheds light on the perception of MaxLinear by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of MaxLinear's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on MaxLinear analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Delving into MaxLinear's Background

Financial Insights: MaxLinear

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Decline in Revenue: Over the 3 months period, MaxLinear faced challenges, resulting in a decline of approximately -49.99% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.

Net Margin: MaxLinear's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -42.69%, the company may encounter challenges in effective cost control.

Return on Equity (ROE): MaxLinear's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -6.26%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): MaxLinear's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -3.92%, the company may face hurdles in achieving optimal financial performance.

Debt Management: MaxLinear's debt-to-equity ratio is below the industry average. With a ratio of 0.25, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

The Core of Analyst Ratings: What Every Investor Should Know

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.